Study to Assess the Long-term Safety of Oral Lacosamide in Subjects With Partial-onset Seizures
| Status: | Completed |
|---|---|
| Conditions: | Neurology, Neurology, Neurology |
| Therapuetic Areas: | Neurology |
| Healthy: | No |
| Age Range: | 16 - 60 |
| Updated: | 7/19/2018 |
| Start Date: | April 2008 |
| End Date: | June 2010 |
A Multicenter, Open-label Extension Trial to Assess the Long-term Safety and Tolerability of Lacosamide as Adjunctive Therapy in Subjects With Partial-onset Seizures
The purpose of this study is to allow eligible subjects from the parent study, SP925
[NCT00655551] to continue lacosamide and to obtain additional long-term safety data
[NCT00655551] to continue lacosamide and to obtain additional long-term safety data
A multicenter, open-label extension study to assess the long-term safety and tolerability of
lacosamide as adjunctive therapy in subjects with partial-onset seizures who were previously
enrolled in the SP925 study [NCT00655551] (intravenous lacosamide loading dose followed by
approximately 1 week of oral lacosamide maintenance).
lacosamide as adjunctive therapy in subjects with partial-onset seizures who were previously
enrolled in the SP925 study [NCT00655551] (intravenous lacosamide loading dose followed by
approximately 1 week of oral lacosamide maintenance).
Inclusion Criteria:
- Eligible subjects who participated in SP925 [NCT00655551] for treatment of
partial-onset seizures
Exclusion Criteria:
- Receiving any study drug or experimental device other than lacosamide
- Meets withdrawal criteria for parent study SP925 [NCT00655551]
- Experiencing ongoing serious adverse event
We found this trial at
7
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials